Isomorphic Labs, an AI-powered drug discovery spinoff from Google DeepMind, raised $2.1B led by Thrive, after raising $600M in its first round in March 2025
Isomorphic Labs, an artificial intelligence-driven drug discovery company, said on Wednesday it has raised $2.1 billion …
Reuters Pritam Biswas
Related Coverage
- Alphabet's Isomorphic Labs raises $2.1bn in Series B funding Silicon Republic · Laura Varley
- Isomorphic Labs raises £1.6bn to scale AI drug design engine UKTN · Kirstie Pickering
- Isomorphic Labs lands $2.1BN investment Tech.eu · John Reynolds
- Isomorphic Labs receives $2.1bn for AI drug development Pharmaceutical Technology · Salong Debbarma
- DeepMind CEO Demis Hassabis' Isomorphic Labs raises $2.1 billion led by Thrive Capital The Economic Times
- Isomorphic Labs Raises $2.1 Billion Series B To Scale AI Drug Design Engine And Advance Therapeutic Pipeline Pulse 2.0 · Amit Chowdhry
- Elon Musk, Sam Altman and the world's billionaires are terrified of the Google AI genius behind a 25-year-old computer game, because they think he might actually end up controlling god PC Gamer · Rich Stanton
- Isomorphic Labs raises $2.1 billion Series B for AI drug discovery Quartz
- Isomorphic Labs raises $2.1B for AI drug discovery Axios · Katherine Davis
- Alphabet's Isomorphic Labs raises $2.1 billion to scale AI drug discovery toward clinical trials The Decoder · Matthias Bastian
- Isomorphic Labs raises $2.1 billion Series B for AI drug discovery Yahoo Finance · Cris Tolomia
- Alphabet's AI biotech Isomorphic Labs bags $2.1B series B to fuel next-gen drug design model Fierce Biotech · James Waldron
- Five burning questions for Isomorphic after its mammoth $2B+ raise Endpoints News · Andrew Dunn
- DeepMind spinout Isomorphic Labs raises $2.1bn Sifted · Freya Pratty
- DeepMind Spinout Isomorphic Labs Raises $2.1 Billion to Design Drugs With AI Bloomberg
- Alphabet-spinoff Isomorphic Labs raises $2.1 billion in quest to ‘solve all disease’ with AI-based drug discovery tools Research & Development World · Brian Buntz
- What drones and drug discovery have in common Fortune · Allie Garfinkle
- Sovereign AI fund supports Hassabis startup, Isomorphic ComputerWeekly.com · Cliff Saran
Discussion
-
@demishassabis
Demis Hassabis
on x
I've always believed the No.1 application of AI should be to improve human health. That work started with AlphaFold, and now at @IsomorphicLabs with the mission to reimagine drug discovery and one day solve all disease! We are turbocharging that goal with $2.1B in new funding. [v…
-
@isomorphiclabs
@isomorphiclabs
on x
Today we announced our $2.1 Billion funding. This is the catalyst that will bring us to a future of medicine with the power of AI. And we are just getting started, come join our mission.
-
@jameswise
James Wise
on x
We're very fortunate to have @demishassabis, @maxjaderberg and the incredible team building Isomorphic based here in the UK - but on a mission to improve health across the globe. Delighted that @UKSovereignAI will be supporting them on this journey.
-
@isomorphiclabs
@isomorphiclabs
on x
Today marks a pivotal moment for Isomorphic Labs. We have secured $2.1 Billion in our second external funding round, led by Thrive Capital. They are joined at the table by Alphabet, GV and new investors MGX, Temasek, CapitalG and the UK Sovereign AI Fund. This milestone [video]